Transforming growth factor-β in myocardial disease

NG Frangogiannis - Nature Reviews Cardiology, 2022 - nature.com
Transforming growth factor-β (TGFβ) isoforms are upregulated and activated in myocardial
diseases and have an important role in cardiac repair and remodelling, regulating the …

[HTML][HTML] The role of the TGF-β superfamily in myocardial infarction

A Hanna, NG Frangogiannis - Frontiers in cardiovascular medicine, 2019 - frontiersin.org
The members of the transforming growth factor β (TGF-β) superfamily are essential
regulators of cell differentiation, phenotype and function, and have been implicated in the …

Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?

M Sweeney, B Corden, SA Cook - EMBO molecular medicine, 2020 - embopress.org
Cardiac fibrosis is central to the pathology of heart failure, particularly heart failure with
preserved ejection fraction (HF p EF). Irrespective of the underlying profibrotic condition (eg …

The role of Smad signaling cascades in cardiac fibrosis

A Hanna, C Humeres, NG Frangogiannis - Cellular signalling, 2021 - Elsevier
Most myocardial pathologic conditions are associated with cardiac fibrosis, the expansion of
the cardiac interstitium through deposition of extracellular matrix (ECM) proteins. Although …

Targeting transforming growth factor-β receptors in pulmonary hypertension

C Guignabert, M Humbert - European Respiratory Journal, 2021 - Eur Respiratory Soc
The transforming growth factor-β (TGF-β) superfamily includes several groups of
multifunctional proteins that form two major branches, namely the TGF-β–activin–nodal …

Ponatinib drives cardiotoxicity by S100A8/A9-NLRP3-IL-1β mediated inflammation

S Tousif, AP Singh, P Umbarkar, C Galindo… - Circulation …, 2023 - Am Heart Assoc
Background: The tyrosine kinase inhibitor ponatinib is the only treatment option for chronic
myelogenous leukemia patients with T315I (gatekeeper) mutation. Pharmacovigilance …

[HTML][HTML] SIRT3 deficiency enhances ferroptosis and promotes cardiac fibrosis via p53 acetylation

H Su, AC Cantrell, JX Chen, W Gu, H Zeng - Cells, 2023 - mdpi.com
Cardiac fibrosis plays an essential role in the development of diastolic dysfunction and
contributes to heart failure with preserved ejection fraction (HFpEF). Our previous studies …

[HTML][HTML] Cardiac fibroblasts and cardiac fibrosis: precise role of exosomes

P Ranjan, R Kumari, SK Verma - Frontiers in cell and developmental …, 2019 - frontiersin.org
Exosomes are a group of extracellular microvesicles that deliver biologically active RNAs,
proteins, lipids and other signaling molecules to recipient cells. Classically, exosomes act as …

Integrated proteomics unveils nuclear PDE3A2 as a regulator of cardiac myocyte hypertrophy

G Subramaniam, K Schleicher, D Kovanich… - Circulation …, 2023 - Am Heart Assoc
Background: Signaling by cAMP is organized in multiple distinct subcellular nanodomains
regulated by cAMP-hydrolyzing PDEs (phosphodiesterases). Cardiac β-adrenergic …

The role of TGF—β signaling in cardiomyocyte proliferation

DW Sorensen, JH van Berlo - Current heart failure reports, 2020 - Springer
Abstract Purpose of Review The loss of contractile function after heart injury remains one of
the major healthcare issues of our time. One strategy to deal with this problem would be to …